Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong You

Showing results (851-860 of 904) with videos related to

Pageof 91
Sort By:
Journal of Digestive Diseases|August 1, 2025
GLOBE Score and UK-PBC Risk Score Predict Long-Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and FenofibrateShu Xiang Li, Bu Er Li, Min Li, et al.
Hepatology International|November 29, 2021
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosisXiaoning Wu, Jia Hong, Jialing Zhou, et al.
Plos Neglected Tropical Diseases|December 16, 2024
Development of a latex microsphere-based lateral flow immunoassay for the diagnosis of schistosomiasis japonicaEmmanuel John Tabilin, Catherine A Gordon, Yi Mu, et al.
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2025
Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated CirrhosisShuai Xia, Zhiying He, Xiaoning Wu, et al.
Chemical Communications (Cambridge, England)|May 30, 2018
Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodiesSachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Chemical Communications (Cambridge, England)|July 3, 2018
Correction: Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodiesSachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Nature Communications|October 12, 2023
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trialYue Hu, Haijun Li, Hong Zhang, et al.
Hepatology International|September 22, 2016
Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016Atsushi Tanaka, Xiong Ma, Osamu Yokosuka, et al.
Hepatology (Baltimore, Md.)|September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosisYameng Sun, Shuyan Chen, Xiaoqian Xu, et al.
Pageof 91

Showing results (851-860 of 904) with videos related to

Sort By:
Pageof 91
Journal of Digestive Diseases|August 1, 2025
GLOBE Score and UK-PBC Risk Score Predict Long-Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and FenofibrateShu Xiang Li, Bu Er Li, Min Li, et al.
Hepatology International|November 29, 2021
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosisXiaoning Wu, Jia Hong, Jialing Zhou, et al.
Plos Neglected Tropical Diseases|December 16, 2024
Development of a latex microsphere-based lateral flow immunoassay for the diagnosis of schistosomiasis japonicaEmmanuel John Tabilin, Catherine A Gordon, Yi Mu, et al.
Scandinavian Journal of Public Health|May 3, 2018
China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis BShan Shan, Wei Wei, Yuanyuan Kong, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2025
Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated CirrhosisShuai Xia, Zhiying He, Xiaoning Wu, et al.
Chemical Communications (Cambridge, England)|May 30, 2018
Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodiesSachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Chemical Communications (Cambridge, England)|July 3, 2018
Correction: Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodiesSachin S Shivatare, Lin-Ya Huang, Yi-Fang Zeng, et al.
Nature Communications|October 12, 2023
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trialYue Hu, Haijun Li, Hong Zhang, et al.
Hepatology International|September 22, 2016
Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016Atsushi Tanaka, Xiong Ma, Osamu Yokosuka, et al.
Hepatology (Baltimore, Md.)|September 1, 2025
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosisYameng Sun, Shuyan Chen, Xiaoqian Xu, et al.
Pageof 91